Pharma2026-10-05 10:50 UTC
Digital Twin Tests Therapies Before Patients Receive Them
A digital twin is being used to test cancer therapies before they are administered to patients.
The digital twin, developed by the German Cancer Consortium, is a virtual replica of a patient's tumor. It allows researchers to test different treatment options and predict their effectiveness. This approach aims to reduce the number of ineffective treatments and minimize side effects.
Source: WELT — read the original article
This article is an independent rewrite and summary, not a reproduction of the original.
← back to feed
This article is an independent rewrite and summary, not a reproduction of the original.